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Abstract.  The Deleted in Colorectal Cancer (DCC) 
gene is a candidate tumor suppressor gene that is 
predicted to encode a transmembrane polypeptide with 
strong similarity to the neural cell adhesion molecule 
(N-CAM) family.  Previous studies have suggested that 
several different N-CAMs, when expressed in non- 
neuronal cell types can stimulate neurite outgrowth 
from PC12  rat pheochromocytoma cells.  Based on the 
predicted structural similarity of DCC to N-CAMs, 
we sought to determine whether NIH3T3 cells ex- 
pressing DCC could stimulate neurite outgrowth in 
PC12  cells. We found that NIH3T3 cell lines express- 
ing DCC could stimulate PC12 cells to extend neu- 
rites. Supernatants from DCC-transfected NIH3T3 
cells did not induce neurite outgrowth above back- 
ground levels,  suggesting  that cell-cell interaction was 
required. NIH3T3 cells expressing a truncated form of 
DCC, lacking the majority of the cytoplasmic domain 
sequences, also failed to induce neurite outgrowth 
above the levels seen with control NIH3T3 cells, sug- 
gesting that the cytoplasmic domain of DCC was 
necessary for its neurite-promoting function. In con- 
trast to NGF-mediated neurite outgrowth, the DCC- 
mediated response was inhibited by treatment with 
pertussis toxin or the combination of N- and L-type 
calcium channel blockers, and was unaffected by the 
transcriptional inhibitor cordycepin. The data suggest 
that the DCC protein can function in a fashion analo- 
gous to other N-CAMs to alter PC12 cell phenotype 
through intracellular pathways distinct from those in- 
volved in NGF signaling. 
T 
HE deleted  in colorectal  cancer  (DCC) l tumor sup- 
pressor  gene was identified and cloned on the basis 
of frequent  genetic  alterations  affecting a region of 
chromosome 18q in colorectal cancers (Fearon et al., 1990; 
Hedrick et al., 1992; Cho et al., 1994). Other studies sug- 
gest that inactivation of the DCC gene may occur, not only 
in colorectal cancer, but also in breast, pancreatic, bladder, 
endometrial, prostate, and squamous cell cancers, as well as 
in some leukemias (Devilee et al., 1991; Hohne et al., 1992; 
Wu et al.,  1991; Imamura et al.,  1992; Gao et al.,  1993; 
Klingelhutz et al., 1993; Porfiri et al., 1993). The sequence 
of human DCC cDNA predicts a  1,447-amino acid trans- 
membrane  polypeptide  whose  four  immunoglobulin-like 
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and six fibronectin type III-like extracellular domains show 
strong similarity to the neural cell adhesion molecule (N- 
CAM) family of cell surface proteins (Fearon et al., 1990; 
Hedrick et al.,  1992). However, the 325-amino acid cyto- 
plasmic domain of DCC shares little similarity with any pre- 
viously characterized proteins. 
A large body of evidence suggests that N-CAMs, cadhe- 
fins, and other cell adhesion molecules may function in de- 
velopment and cell differentiation through both homophilic 
and heterophilic interactions with molecules on the surface 
of opposing cells (Edelman,  1985; Jessell,  1988; Takeichi, 
1991;  Edelman  and  Crossin,  1991).  In  addition,  recent 
studies suggest that members of the N-CAM and cadherin 
families do not merely function in adhesion. Rather, specific 
intracellular signal transduction pathways may be activated 
when cell-cell interactions occur through these molecules 
(Schuch et al., 1989; Doherty et al., 1991, 1993; Walsh and 
Doherty, 1992; Williams et al., 1992). The similarity of the 
predicted amino acid sequence of  DCC with that of  members 
of the N-CAM family suggests that DCC may also function 
to mediate specific cell-cell or cell-extraceUular matrix in- 
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cules that interact with the extracellular domain of DCC or 
the means by which DCC functions in normal or neoplastic 
cell growth. 
Initial studies suggested that the DCC transcripts are pres- 
ent in most adult tissues at very low levels, with highest lev- 
els in brain tissues (Fearon et al.,  1990).  DCC expression 
appears to be higher in fetal brain compared with the levels 
in adult brain tissues (Fearon et al., 1990), although detailed 
studies of DCC gene expression in developing neural tis- 
sues have not yet been carried out. In addition, immuno- 
histochemical analysis has demonstrated DCC expression in 
central and peripheral nervous system tissues of the adult 
(Hedrick, L., K. R. Cho, E. R. Fearon, T.-C. Wu, K. W. 
Kinzler, and B. Vogelstein, manuscript submitted for publi- 
cation). Recent studies using an in vitro model of neuronal 
differentiation and anti-sense  DCC  expression  constructs 
suggest that persistent DCC expression may be necessary in 
some ceils for the morphological differentiation induced by 
nerve growth factor (NGF) (Lawlor and Narayanan, 1992). 
Specifically,  PC12  cells, a rat adrenal pheochromocytoma 
cell line that exhibits  features of neuronal differentiation 
(such as neurite outgrowth) after treatment with NGF, were 
transfected with an anti-sense DCC expression construct. 
There  was  inhibition  of  NGF-mediated  morphological 
differentiation  in cells expressing high levels of  the anti-sense 
DCC transcripts despite the induction of several early re- 
sponse genes by NGE In addition, it was observed that the 
addition of anti-sense DCC oligonucleotides to NGF-differ- 
entiated PC12 ceils caused a morphological reversion of the 
neuronal phenotype. These data have been interpreted as evi- 
dence that expression of DCC in PC12 cells is necessary for 
induction and maintenance of morphological differentiation. 
Previous studies have provided evidence for the critical 
role of at least three different classes of cell-surface pro- 
teins-integrins,  cadherins,  and  immunoglobulin  super- 
family CAMs-in mediating cell-cell recognition and differ- 
entiation in the nervous system in in vivo and in vitro model 
systems of neuronal differentiation and axonal outgrowth 
(Neugebauer  et al.,  1988;  Reichert and Tomaselli,  1991; 
Hynes, 1992; Takeichi, 1991; Edelman and Crossin, 1991; 
Walsh and Doherty, 1991). While in most studies purified 
preparations of N-CAM have not been found to be active in 
promoting  neurite  outgrowth,  NIH3T3  fibroblast  mono- 
layers expressing high levels of N-CAM or N-cadherin will 
stimulate PC12  neurite outgrowth (Doherty et al.,  1991; 
Walsh and Doherty, 1992).  Furthermore, the studies of Do- 
herty, Walsh, and their colleagues have suggested that the 
morphoregulatory activities of N-CAM and N-cadherin in- 
volve activation of G protein-dependent and calcium chan- 
nel-dependent  signaling  pathways.  Because  DCC  shares 
common structural motifs with members of  the N-CAM fam- 
ily (Ig-like domains and fibronectin type HI repeats),  we 
sought to  investigate whether the expression of DCC  in 
NIH3T3 fibroblasts could stimulate PC12 neurite outgrowth, 
and if so, to explore some of the mechanisms by which this 
response is regulated. In this report, we demonstrate that 
DCC can function in a fashion similar to other cell adhesion 
molecules, like N-CAM and N-cadherin, to stimulate mor- 
phological differentiation of PC12 cells. These data support 
the proposal that the DCC tumor suppressor gene product 
may function in differentiation pathways and cell fate deter- 
mination through cell-cell interactions. 
Materials and Methods 
Plasmid Constructs 
The mammalian cell expression vector pCMVNeoXhoI was used to gener- 
ate all DCC expression constructs (see Fig. 1). In this vector eDNA expres- 
sion is driven by a potent cytomegalovirus promoter/enhancer element; the 
vector also confers resistance to G418 in mammalian cells under control 
of herpes simplex thymidine kinase promoter and poly-adenylation ele- 
ments (Baker et al., 1990).  The vector pCMV/DCC-S contains full-length 
DCC eDNA sequences (nucleotides -15 to 4496), encoding amino acids 
1 to  1447. The pCMV/DCC-T vector encodes a truncated form of DCC 
lacking  amino  acids  1156-1447;  the  cytoplasmic  domain  of DCC  is 
predicted to begin at amino acid 1121. A vector encoding an extremely trun- 
cated (mutant) DCC polypeptide with only the signal sequence and a por- 
tion of  the first immunoglobulin-like domain of DCC (pCMV/DCC-M) was 
generated by deleting the two central nucleetides from a unique SstII site 
at nucleotide 189. The ,~50-amino acid polypeptide produced from cells 
expressing DCC-M is predicted to be secreted into the media. Supercoiled 
plasmid DNAs were purified on CsCI gradients. 
Cell Lines 
NIH3T3  cells were obtained  from  American Type Culture  Collection 
(Rockville, MD) and were routinely maintained in DME supplemented 
with 10% fetal bovine serum (FBS), 100 IU/ml of penicillin and 100 t~g/ml 
of streptomycin (P/S) at 37°C/5% CO2 (GIBCO BRL [Life Technologies, 
Inc.l Gaithersburg, MD). PC12 cells were obtained from ATCC and were 
maintained in RPMI 1640 medium supplemented with 5 % FBS, 10% horse 
serum (heat inactivated at 56°C for 30 rain) and P/S at 37°C/5% CO2. For 
the neurite outgrowth assay both PC12 and NIH3T3 cells were cultured in 
SATO  media  (Bottenstein,  1985),  containing  DME  (GIBCO  BRL), 
progesterone (0.062  rag/liter),  putrescine (16.6 rag/liter),  thyroxine (0.4 
rag/liter), selenium (0.039 mg/liter), human transferrin (100 rag/liter), bo- 
vine pancreas insulin (10 rng/liter), and triiodothyronine (0.377  rag/liter) 
(all reagents other than DME from Sigma Chemical Co., St. Louis, MO). 
DNA Transfections 
To generate NIH3T3  cell lines expressing the various DCC eDNA con- 
structs,  DNA  transfeetions were  carried  out  using  Lipofeetin Reagent 
(GIBCO BRL). In brief, NIH3T3 cells were transfeeted with a mixture of 
3 ~g of plasmid DNA and cationic liposomes in sernm-free media. After 
an overnight incubation, the cells were washed and complete media was 
added. On the second day after transfection, selection in G418 at a concen- 
tration of 600 #g/ml was begun. Single G418-resistant clones were tryp- 
sinized and established as clonal cell lines. Once established, the clonal cell 
lines were maintained in G418  at 400 ~g/ml. 
Ribonuclease Protection Assay 
Total RNA was isolated from the various cell lines as described previously 
(Chomczynsld and Sacchi, 1987). A radiolabeled DCC antisense riboprobe 
transcript was prepared from the plasmid pBSH/DCC-RB, which contains 
a 400-bp EcoRI-BamHI DCC cDNA fragment (containing sequences en- 
coding the distal extracellular, transmembrane, and proximal cytoplasmic 
domains of DCC-amino acids  1(Y21-1155), using T7  RNA polymerase 
(GIBCO  BRL).  The  approximately  480-bp  32p-labeled  transcript  was 
purified by electrophoresis, and 5.0  ×  105 cpm of transcript was incubated 
overnight at 48°C with 25/~g of total RNA in hybridization solution (80% 
deionized formamide; 40 mM 1,4-piperazinediethane sulfonic acid [Pipes], 
pH 6.4; 400 mM NaCI;  1 mM EDTA). Ribonuclease digestion was then 
carried out for 1 h at 30°C using 7.5 U of RNase "12 (GIBCO BRL) in 250 
/~1 of digestion buffer (50 mM sodium acetate, pH 4.4;  100 mM NaC1;  10 
mM EDTA). RNA was precipitated with isopropanol, resuspended in RNA 
loading buffer (90% deionlzed formamide; 10 mM EDTA;  0.2% bromo- 
phenol blue; 0.2% xylene cyanol), heated for 3 rain at 90°C, and electro- 
phoresed on a denaturing polyacrylamide gel. After drying of the gel, auto- 
radiography  was  carried  out  with  intensifying screens and  Hyperfilm 
(Amersham Corp., Arlington Heights, IL). 
Western Blot Analysis of  DCC Expression 
Western blot analysis was carried out on lysates from the various NIH3T3 
cell lines. Confluent monolayers of cells were washed and lysed directly in 
Laemmli sample buffer or in RIPA buffer (25  mM Tris[hydroxymethyl]- 
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fate, 1% nonidet P-40) supplemented with 10/~g/ml phenylmethylsulfonyl 
fluoride (PMSF), 50 ~g/ml antipain, 5/~g/ml aprotlnin, and 2/~g/ml leupep- 
tin (all prote&se inhibitors purchased from Sigma Chednieal Co.). Protein 
concentrations were determined using the BCA Protein Assay Reagent 
(Pierce,  Rockford,  1L).  Proteins were  separated by electrophoresis on 
SDS/pelyacrylamide gels and transferred to lmmobilon P membranes (Mil- 
lipore Corp., Bedford, MA) by semi-dry electroblotting. DCC  proteins 
were detected using each of  three different affinity-purified,  polyclonal, rab- 
bit anfi-DCC antisera as the primary antibody and horseradish peroxidase- 
conjugated goat anti-rabbit immtmoglobulin antibody (Amersham Corp.) 
as the secondary reagent. One of  the anti-DCC antisera was directed against 
an extraceilular domain peptide epitope derived from sequences located be- 
tween the sixth fibronectin type HI repeat and the transmembrane region 
of DCC (sera 645); another anti-DCC antisera was directed a t,  ainst a jux- 
tamembrane cytoplasmic domain peptide epitope (sera 641);  and the third 
anti-DCC antisera was directed a mainst a recombinant bacterially produced 
fusion protein coutaining cytoplasmic domain sequences (sera 721). Detec- 
tion of antibody complexes was carried out with the Enhanced Chemilumi- 
nescence (ECL) Western Blot Kit (Amersham Corp.) and subsequent ex- 
posure to Hyperfilm (Amersham Corp.). 
Immunofluorescence Studies of DCC Expression in 
Transfected Cells 
NIH3T3 cell lines were fixed in 4 % paraformaldehyde in phosphate buffered 
saline (PBS) for 30 rain at room temperature. The cells were then washed 
and stained with a primary mouse monoclonal antibody directed against 
DCC extracellular domain sequences (Oncogene Science, Manhasset, NY) 
at  a  concentration of 0.2  t~g/ml  in  PBS  and  a  secondary,  rhodamine- 
conjugated,  goat  anti-mouse  immunoglobulin  antibody  (Jackson  Im- 
munoReseareh Laboratories, Inc., Westgrove, PA) at a concentration of 1.5 
/~g/rni. Coverslips were then mounted with Gel-Mount (Biomeda Corp., 
Foster City, CA), and the cells were examined and photographed in phase 
and under fluorescence optics on a Nikon FAX microscope. 
Cell Surface Biotinylation 
NIH3T3 ceil lines were grown to 80% confluence in 75-cm  2 tissue culture 
flasks. The cells were washed twice with PISS, and 3 rni of biotinylation 
buffer (10 mM sodium borate, 150 mM NaC1, pH 8.8) and 15/~1 of 10 mg/ml 
D-biotinyl-epilson-amidocaproic acid N-hydroxysuccinimide ester (biotin- 
CNHS-ester; Boehringer Mannheim Corp., Indianapolis, IN; freshly made 
and dissolved in dimethyl sulfoxide) were added to the flask (Meier et al., 
1992).  The flask was rocked gently at room temperature for 15 rain, and 
30/d of 1 M NI-hCI was then added to terminate the reaction. The cells 
were washed twice with PBS and lysates were prepared in RIPA buffer with 
protease inhibitors. Immunoprecipitations were carried out with affinity- 
purified rabbit anti-DCC antisera 645 and Protein A (Pierce, Rockford, IL) 
as described (Harlow and Lane, 1991), and the biotinylated proteins were 
detected using avidin/bintin-conjugated horseradish peroxidase (Pierce) 
and ECL, as described above. 
Neurite Outgrowth Assay 
Cell Culture and Reagents.  Approximately 5  ×  104 cells of each of the 
NIH3T3 cell lines were plated in DME/10%FBS and P/S on two-chamber 
glass slides (Nunc, Roskilde, Denmark), coated with poly-d-lysine and rat 
tail collagen type I (Collaborative Research, Bedford, MA), and grown to 
70% confluence at 37*C/5% CO2. To establish the NIH3T3 and PC12 co- 
cultures,  DME/10%FCS  was  removed and  5.0  ×  103 PC12  cells were 
added to the NIH3T3 ceil monolayers in 1 ml of SATO medium (Doherty 
et at., 1988) per chamber. For the experiments in which nerve growth factor 
and/or other compounds were ~dministered to the co-cultures, these re- 
agents were added at the time of  the PC12 cell addition to the NIH3T3 cells. 
The various reagents included: murine nerve growth factor 2.5S subanit 
(GIBCO BRL); cordycepin (1 ~M) (Boehringer Mannbeim, Indianapolis, 
IN);  pertnssis toxin (1  t~g/ml)  (GIBCO  BRL);  cholera toxin (1  ng/ml) 
(GIBCO BRL);  diltiazem (10 ~,M) (Sigma Chemical Co.); w-conotoxin 
(0.25/~M)  (Sigma Chemical Co.). 
Immunofluorescence Detection of  PC12 Cells and 
Scoring of Neurite Outgrowth 
After 48 h of co-culture at 37*C/5% CO2,  the cell cultures were fixed in 
4% paraformaldehyde in PBS for 30 min. PC12 cells were stained with the 
addition of a mouse anti-rat Thy-1 monoclonal antibody (GIBCO BRL) at 
a dilution of 1:100 in PBS for 1 h. After washing with PBS, ceils were in- 
cubated sequentially with a goat anti-mouse biotinylated secondary anti- 
body and a streptavidin-Texas red conjugate (Amersham Corp.), each for 
1 h at a dilution of 1:500 in PBS. Ceils were then washed with PBS, cover- 
slips were mounted, and the Thy  1  + PC12 were visualized under rhoda- 
mine optics on a Nikon FAX microscope. The percentage of Thyl + PCl2 
ceils with at least one neurite >20 ~m in length was determined. An eye- 
piece with a micrometer scale was used to assess the 20/an length. For each 
experiment, >100  randomly selected Thyl + PC12  cells were studied in 
each chamber. For each of the various inhibitor treatments, three to seven 
independent  experiments were performed. For the experiments displayed in 
Figs. 5, 6, and 7, all slides were blinded with regard to the NIH3T3 ceil line 
used and the particular treatment before determination of the percentage of 
Thyl + cells with neurites greater than 20 t~m in length. To characterize the 
length of the longest neurite per cell (Table I), PCl2 cells were cultured on 
the NIH3T3 cell monofayers and stained as described above. The longest 
neurite on each of 100 Thyl + PC12 cells was measured using a Zeiss Ax- 
iophot microscope and a Sony DXC-760 MD CCD camera connected to 
a Sony Triniton monitor. 
Supernatant Experiments 
The transfccted NIH3T3 DCC-expressing cell line 1A1 and the control cell 
line 3A3 were grown to 70%  confluence in DME/10%  FCS/PS on two- 
chamber slides, as described above. The DME/10%FCS vats then removed, 
the cells were washed once with SATO media, and 1 ml of SATO media, 
with or without the supplementation of 50 ng/rni NGF, was added. After 
48 h of  culture, the conditioned SATO media was removed, filtered through 
0.2  p.m  polycarbonate,  low  protein-binding filters  (Acrodisc,  Gelman 
Sciences, Ann Arbor, MI) and used as the media for PC12 neurite out- 
growth in separate co-culture experiments as described above. 
Results 
Generation of NIH3T3 Cell Lines Expressing 
DCC Proteins 
NIH3T3 cells were transfected with a eukaryotic expression 
vector encoding a full-length  human DCC eDNA under con- 
trol ofa cytomegalovirus  promoter (Hedrick, L., K. R. Cho, 
E. R. Fearon, T.-C. Wu, K. W. Kinzler, and B. Vogelstein, 
manuscript submitted for publication). This vector also con- 
fers resistance to G418. In addition, two constructs encoding 
altered forms of DCC were also transfected into NIH3T3 
cells (Fig. 1). One eDNA, termed DCC-T, encodes a protein 
lacking the 292 earboxy-terminal amino acids of DCC. The 
other (DCC-M) encodes a severely truncated form of DCC 
containing only the signal sequence and a portion of the first 
immunoglobulin-like domain. Assuming removal of the sig- 
nal sequence, only a 50-amino acid polypeptide would be 
produced and secreted into the media from cells expressing 
the DCC-M eDNA construct, despite the fact that the DCC 
mRNA produced from the vector is only subtly different 
from that produced from DCC-S (see Materials and Meth- 
ods). After transfection of the constructs into NIH3T3 cells, 
G418-resistant colonies were selected. Upon expansion of 
these colonies into elonal cell lines, the cell lines were tested 
for DCC gene expression using anti-sense RNA probes and 
a  ribonuclease (RNase)  protection assay.  A  480-bp  ribo- 
probe containing DCC sequences was synthesized and hy- 
bridized to RNA prepared from a number of cell lines, in- 
cluding  the  parental  NIH3T3  cells,  the  G418-resistant 
transfected cell lines, and IMR32, a human neuroblastoma 
cell line that expresses  endogenous DCC transcripts.  As 
shown in Fig. 2 A, a heterogeneous pattern of  protected RNA 
fragments was observed in all transfected NIH3T3 cell lines; 
however, protected RNA fragments were not seen in control 
Pierceall et al. DCC and PC12 Neurite Outgrowth  1019 Figure L DCC cDNAs transfected into NIH3T3 cell lines. The full- 
length DCC eDNA (DCC-S) is predicted to encode a 1,447-amino 
acid  transmembrane protein with  four immunoglobulin-like do- 
mains, six fibronectin type III domains, and "~325 amino acids of 
cytoplasmic domain sequences. A truncated DCC eDNA (DCC-T) 
has a deletion predicted to remove "~292 amino acids from the car- 
boxy terminus of the full-length protein.  THE DCC-M eDNA is 
predicted to encode a severely truncated DCC protein containing 
only the signal sequences and a portion of  the first immunoglobulin- 
like domain. 
RNA preparations,  such as yeast RNA or parental NIH3T3 
cells. The level of endogenous DCC transcripts in the IMR32 
cell line was well below that seen in the transfected cells, and 
protected  fragments  could  only  be detected  after long  ex- 
posure.  The  basis  for  the  heterogeneous  pattern  of tran- 
scripts detected by the RNase protection assay of the trans- 
fected  NIH3T3  cell  lines  is  unknown.  However,  multiple 
different DCC transcripts  may be synthesized  in the trans- 
fected lines as a  result of the integration of both intact and 
rearranged  DCC  cDNA  sequences  following  DNA  trans- 
fection. 
Western  blot analysis  of lysates  prepared  from  the  cell 
lines was next performed using two different,  aflinlty-puri- 
fled,  polyclonal  rabbit anti-DCC  antisera.  Antisera  641  is 
directed against a juxtamembrane peptide epitope from the 
cytoplasmic  domain  of DCC;  this  antisera  would  be  ex- 
pected  to  react  with  both  the  full-length  and  truncated 
(DCC-T) forms of DCC. In contrast, antisera 721 was gener- 
ated against a bacterially-produced recombinant fusion pro- 
tein containing the DCC cytoplasmic domain sequences that 
were deleted  from the truncated  DCC  (DCC-T) construct. 
Neither of these two antisera would be expected to react with 
the •50-amino  acid mutant DCC polypeptide predicted to 
be produced by the DCC-M eDNA.  As shown in Fig. 2, B 
and  C,  the  full-length  DCC  protein was expressed at high 
levels in NIH3T3 cell lines 1A1 and 1A2, as well as in IMR32 
cells, but was expressed at quite reduced levels in clone 1E2. 
The DCC-T protein was detected in the cells transfected with 
the DCC-T  cDNA  construct  (cell  lines  2A3  and 2B2),  al- 
though DCC-T expression in the 2B2 cells could only be de- 
tected after long exposure (Fig. 2 C and data not shown). No 
DCC protein was detected  in the cells transfected with the 
DCC-M  eDNA construct  (cell lines  3A3  and  3A6). 
DCC Proteins Are Expressed on the Cell Surface 
Based on the predicted amino acid sequence of DCC,  both 
the full-length and truncated DCC (DCC-T) proteins would 
be expected to be expressed on the cell surface.  To demon- 
strate that the NIH3T3 cell lines expressing  DCC proteins 
properly sorted and delivered the DCC protein products to 
Figure 2.  DCC  gene  and  protein  expression  in  the  transfected 
NIH3T3 cell lines. (A) Ribonuclease (RNase) protection assay of 
DCC gene expression in transfected cell lines and controls.  Ap- 
proximately 25 #g of total RNA from each sample was subjected 
to RNase protection analysis with a 480-bp 32P-labeled DCC an- 
tisense RNA probe. Approximately 1,500  cpm of the undigested 
probe is shown at the left.  Protected fragments were seen in the 
transfected cell lines at this exposure, and in IMR32 upon long ex- 
posure. No protected fragments were seen in the parental NIH3T3 
(3T3-wt) cell RNA or the yeast torula RNA (tRNA). The position 
of the predicted 400 bp protected DCC-specific fragment is indi- 
cated by the arrowhead. (B) Western blot analysis of DCC expres- 
sion using a rabbit polyclonal antisera (721) directed against DCC 
cytoplasmic domain sequences. Approximately 100 #g of  total pro- 
tein was loaded on each lane 
and  SDS-PAGE  was  carried 
out on an 8 % gel. After trans- 
fer of proteins to Immobilon 
membranes, DCC protein was 
detected by ECL. The mobil- 
ity of molecular weight mark- 
ers  (in  kilodaltons  [kD])  is 
indicated at the left. The full- 
length  DCC  protein,  migrat- 
ing at approximately 170-185 
kilodalton (kD), is detected in the transfected cell lines IA1 and 1A2, and the neumblastoma line IMR32. A cross-reactive band at '~110 
ED is detected in all cell lines. Note that the ECL detection system is non-linear, and based on other exposures, the level of DCC expression 
in IMR32 is significantly less than those seen in the  IAI and  1A2 transfected cell lines.  (C) Western blot analysis of DCC expression 
using a rabbit polyclonal antisera (641) raised against a DCC cytoplasmic, juxtamembrane peptide. Immunoreactive proteins were detected 
by ECL. The position of molecular weight markers (in kD) is indicated at the left. The mobility of the full-length DCC protein detected 
in the 1A1, 1A2, and 1E2 cell lines is indicated.  The DCC-T protein has a mobility of ~o140 kD.  DCC-T expression in 2B2 cells could 
be detected in longer exposures. 
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the surface of the transfeeted 
NIH3T3 cells. (A) Cells were 
fixed in 4 % paraformaldehyde 
and  stained  with  a  mouse 
monoclonal  antibody  against 
DCC extracellular domain se- 
quences  and  a  rhodamine- 
conjugated  goat  anti-mouse 
immunoglobulin  antibody. 
Cells were photographed  un- 
der fluorescence (a and b) or 
phase (c and d) optics; (a and 
c)  IA1 ceils;  (b and d)  3A3 
ceils.  Specific  staining  was 
seen only in 1A1 cells. (B) Bi- 
otinylation of full-length and 
truncated  DCC proteins.  Bi- 
otinylation of cell surface pro- 
teins was carried out in vitro. 
Cell  lysates  were  subjected 
to  immunoprecipitation  with 
control purified rabbit immu- 
noglobulin  (IgG)  or a  poly- 
clonal  rabbit  antisera  (645) 
directed  against  an  extracel- 
lular  domain  DCC  peptide; 
and immunoprecipitates  were 
electrophoresed  on  a  10% 
SDS-polyacrylamide  gel  and 
transferred  to  an Immobilon 
membrane. Biotinylated ceU surface proteins were detected by an avidin/horseradish 
peroxidase reagent and ECL. Full-length DCC protein was detected in IA1 cells; 
truncated  DCC protein was seen in 2A3 and 2B2 ceils;  and no DCC protein was 
detected in the 3A3 cells. Several lower molecular weight protein species were also 
detected; some may represent partially proteolyzed DCC polypeptides. The mobil- 
ity of molecular  weight markers (in kD) is indicated at the left. Bar, 25 #m. 
the cell surface, we performed immunotluorescence studies 
with anti-DCC antibodies on the cell lines, after fixation, but 
without permeabilization of the cells. As shown in Fig. 3 A, 
a mouse monoelonal antibody directed against an extracellu- 
lar domain epitope of DCC stained the DCC-expressing 1A1 
cells (a), but did not demonstrate specific staining of the 3A3 
cells (b). The 2A3 and 2132 cell lines did not demonstrate 
staining above background levels with the monoclonal anti- 
DCC antibody (data not shown). However, as demonstrated 
previously by Western blotting, the level of DCC-T protein 
expression in the 2A3 and 2B2 ceU lines was reduced com- 
pared to the level of full-length DCC protein expression seen 
in the 1A1 cells. Therefore, to demonstrate that the truncated 
DCC protein was also expressed on the cell surface, biotiny- 
lation of cell surface proteins in several of the NIH3T3 cell 
lines was carried out in vitro. Cell lysates were then prepared 
and immunoprecipitation with an antibody directed against 
an  extraceUular domain  epitope of DCC  was performed. 
Both the full-length and truncated DCC proteins were found 
to be biotinylated (as evidenced by their reactivity with an 
avidin reagent when transferred to a membrane), confirming 
that  both  full-length  and  truncated  DCC  proteins  are  ex- 
pressed at the cell surface (Fig. 3 B). Moreover, the relative 
abundance of total DCC protein to cell-surface DCC protein 
appeared to be similar in the 1A1 and 2A3 cell lines (com- 
pare Fig.  3 B  with Fig.  2  C). 
Pierceall et al. DCC and PC12 Neurite  Outgrowth  1021 Figure 4. PC12 neurite outgrowth on NIH3T3 monolayers is stimulated by NGF or DCC. PC12 cells were cultured in SATO media for 
48 h on control 3A3 monolayers (,4 and B) or the DCC-expressing 1A1 cell monolayer (C). In//, NGF was supplemented at 50 ng/ml. 
PC12 ceils were specifically identified by immunostaining with a mouse anti-rat Thy-1 monoclonal antibody. Bar, 25 ~m. 
DCC Expression in NIH3T3 Cells Stimulates Neurite 
Outgrowth in PC12 Cells 
We next sought to determine whether the cell lines express- 
ing the full-length DCC protein could stimulate neurite out- 
growth in PC12 cells.  In brief, PC12 ceils were plated in 
defined media on monolayers of each of  the various NIH3T3 
cell lines,  including  the parental  NIH3T3  cells;  the full- 
length DCC-expressing cell lines IA1, IA2, and 1E2; and the 
control G418-resistant cell lines 3A3 and 3A6. After 48 h of 
co-culture, in the presence or absence of NGF supplementa- 
tion,  the degree of neuronal differentiation in  PC12  cells 
staining positively for the Thy  1 antigen (Thyl  +) was  as- 
sessed by immunofluorescent  microscopy. As the antibody to 
Thyl only binds to the PC12 cells, PC12 ceils growing on 
the NIH3T3 cell monolayers could be rapidly detected and 
neuronal differentiation assessed.  In Fig. 4,  representative 
examples of Thyl+ PC12 cells obtained after several differ- 
ent culture conditions are  shown.  The majority of Thyl  + 
PC12 cells failed to exhibit a  significant degree of neurite 
outgrowth when cultured on monolayers of control NIH3T3 
cell lines in the absence of NGF (Fig. 4 A). Supplementation 
of the defined growth media with NGF, however, stimulated 
significant neurite outgrowth in ,o30% of the Thyl  + PC12 
cells  (Fig.  4  B).  Moreover,  co-culture of PC12  cells  on 
DCC-expressing NIH3T3 cell lines, even in the absence of 
NGF addition, led to detectable neurite outgrowth in •35- 
40% of the PC12 cells (Fig. 4  C). 
To quantitate the effect, the percentage of PC12 cells un- 
dergoing morphological neuronal differentiation was deter- 
mined after 48 h of co-culture on a monolayer of each of the 
various  cell  lines,  in  the  presence  or  absence  of NGF. 
Thyl  + PC12 cells were scored positively for neuronal dif- 
ferentiation if they had  at  least one neurite greater than 
20 ~m in length. This criteria for PC12 neuronal differentia- 
tion has been used previously in experiments demonstrating 
that N-CAM and N-cadherin can stimulate PC12 neurite out- 
growth (Doherty et al., 1991; Walsh and Doherty, 1992). In 
the experiments shown in Fig. 5, 21.7%  ±  1.4%  (mean  ± 
SEM) of the Thyl  + PC12 cells underwent neuronal differen- 
tiation when cultured, in the absence of NGE on the control 
3A3 cells. This background level of PC12 neurite outgrowth 
may result from the synthesis of NIH3T3 cells of a variety 
of soluble factors, such as fibroblast growth factors, or ex- 
tracellular matrix components, such as fibronectin and lami- 
nin,  which  are capable of inducing neurite outgrowth in 
PC12 cells (Togari et al., 1985; Lumsden and Davies, 1986; 
Heffner et al.,  1990; Reichardt et al.,  1990;  Sanes et al., 
1990;  Walsh and Doherty,  1992).  After NGF addition to 
control 3A3 cell monolayers, the percentage of PC12 cells 
with at least one neurite >20 #m in length increased to 31.7 % 
+  1.1%. In the absence of NGF addition, the various DCC- 
expressing NIH3T3 cell lines induced 31.5%  ±  0.3% (1A2 
cells) to 39%  ±  1.7% (IA1 cells) of PC12 cells to undergo 
neuronal differentiation. After addition of NGF to the co- 
cultures containing DCC-expressing NIH3T3 cells, the per- 
centage of  PC12 cells undergoing neuronal differentiation in- 
creased to 37.5%  ±  1.1% to 42%  ±  0.5%. 
Thus, NIH3T3 cell lines expressing DCC stimulated neu- 
rite outgrowth in PC12 cells, and NGF appeared to have an 
additive effect on this process. Other control cell lines, such 
as the parental NIH3T3 cells and NIH3T3 cell lines trans- 
fected solely with a G418-resistance element, showed essen- 
tially the same results as the 3A3 control cell line (data not 
shown). When compared with the control 3A3 cell mono- 
layer, the effect of DCC expression on stimulation of neurite 
outgrowth was highly significant (P < 0.001). In addition, the 
relative level of DCC expression in the transfected NIH3T3 
cells did not appear to be particularly critical, as NIH3T3 
cell lines that varied greatly in their level of expression of 
DCC protein (1A1 vs.  1E2) induced a similar percentage of 
Thyl  + PC12 cells to undergo neuronal differentiation. The 
variation in percentage of Thyl  + PCI2 cells with at least one 
neurite  >20  pm  in  length  between  the  various  DCC- 
expressing  NIH3T3  cell  monolayers was  not  statistically 
significant.  The  variation  observed  between  the  DCC- 
expressing cell lines might simply reflect clonal variations in 
other factors which may influence neurite outgrowth, such 
The Journal of Cell Biology, Volume  124, 1994  1022 Figure 5. NIH3T3 cell lines expressing full-length DCC stimulate 
PC12 neurite  outgrowth.  The results of PC12 co-culture  experi- 
ments, in the presence  (50 ng/ml) or absence of NGF, on control 
NIH3T3 (3A3), three DCC-S-expressing (IA1, 1A2, 1E2), and two 
DCC-T-expressing (23,3, 2B2) cell monolayers are shown. The per- 
centage  (+SEM)  of Thyl  + PC12 cells  with  at least  one neurite 
>20 ~m in length after 48 h of culture is indicated. Each value was 
derived from the analysis of more than  100 Thyl  + PC12 cells in 
two to four independent experiments. All experiments were blinded 
with regard to the identity of the N1H3T3 cell monolayer prior to 
the assessment of PCI2 neuronal differentiation. 
as the secretion of fibroblast growth factor and extracellular 
matrix components. 
Previous studies of the effects of N-CAM and N-cadherin 
have shown that NIH3T3 cells expressing these molecules 
not only increase the percentage of PC12 cells with neurons 
greater than 20 t,m in length,  but also increase the mean 
length of the longest neurite per cell. Culture of PC12 cells 
for 48 h  on NIH3T3 cell monolayers expressing DCC in- 
creased the mean neurite length of  the longest neurite per cell 
when compared with the mean neurite length observed when 
PC12 cells were plated on the control 3A3 monolayer (Table 
I). This effect was seen with three different DCC-S-express- 
ing monolayers (1A1, 1A2, 1E2), but the effect on mean neu- 
rite  length  observed in  analysis  of 100  Thyl+PC12  cells 
co-cultured  with each respective cell line did  not achieve 
statistical  significance when compared to the control 3A3 
monolayer. Therefore, the percentage of PC12 cells with at 
least one neurite greater than 20 ~,m was used to analyze all 
further studies.  As expected NGF treatment increased the 
mean neurite length of the longest neurite per cell in all cul- 
tures (Table I). 
The Cytoplasmic Domain of  DCC Is Required for 
Mediating Neurite Outgrowth 
Previous studies of several CAMs, including E-cadherin and 
N-cadherin,  have established that the cytoplasmic domain 
sequences are critical for mediating appropriate cell-cell in- 
teraction  (Takeichi,  1991).  Thus,  we  sought to determine 
whether the cytoplasmic domain of DCC was necessary for 
inducing neurite outgrowth in PC12 cells. The 2A3 and 2B2 
cell  lines expressing the DCC-T protein were assayed for 
their ability to stimulate neurite outgrowth in PC12 cells. As 
shown in Fig. 5,  in the absence of NGF, the 2A3 and 2B2 
cell lines failed to stimulate neurite outgrowth above the lev- 
els seen with the 3A3 control cell line. We also found that 
the 23.3 and 2B2 cell lines failed to increase the mean neurite 
length of the longest neurite per cell (Table I). As demon- 
strated above (Fig. 3 B), both the 2A3 and 2B2 cell lines ex- 
press DCC-T protein on the cell surface. Thus, a possible ex- 
planation  for the results  is that the  absolute levels of cell 
surface DCC expression in the 2A3 and 2132 lines may not 
be sufficient for inducing PC12 neurite outgrowth. However, 
the  1E2  cell line,  which expressed less total DCC protein 
than 2A3 (see Fig. 2  C), was able to induce PC12 neurite 
outgrowth despite low level expression of DCC. The data, 
therefore, suggest that DCC cytoplasmic domain sequences 
are necessary for inducing  PC12 neurite outgrowth. 
Supernatants from DCC-expressing Cells Fail to 
Stimulate Neurite Outgrowth 
To demonstrate that  the  stimulation  of PC12  neurite  out- 
growth by DCC resulted from cell-cell interactions and not 
from a  soluble  factor(s)  secreted  by the  DCC-expressing 
cells, we determined if supernatants from the 1A1 cell line 
were  sufficient  for induction  of PC12  neurite  outgrowth. 
Monolayers of DCC-expressing 1A1 cells and the control cell 
line 3A3  were prepared in the same manner as for the co- 
culture experiments, except that no PC12 cells were added. 
After culturing the monolayers for 48 h in the SATO media, 
Table L  Mean Neurite Length of the Longest Neurite per PC12  Cell When Plated on Control or DCC-expressing 
NIH3T3 Cell Monolayers 
Monolayer cell line  Neufite length (~m)/c¢11" (-NGF)  Neurite length (~m)/cell* (+NGF)) 
DCC-M-transfectant (control) 
(3A3)  11.7  +  2,2  28.7  +  4.2 
DCC-S-transfectants 
(1A1)  15.7 +  2.1  35.6 +  3.9 
(1E2)  17.0 +  2.5  24.8  +  3.6 
(1A2)  16.9 +  2.7  24.7  +  3.7 
DCC-T-transfectants 
(2A3)  8.1  +  1.6  13.1  +  2.1 
(2B2)  10.6 +  2.2  19.1  +  2.6 
* Mean  5= standard  error of the mean;  100 Thyl  + PCI2 cells analyzed for each monolayer and each NGF condition. 
NGF supplemented at 50 ng/ml in the culture media. 
Pierceall et al. DCC and PC12 Neurite Outgrowth  1023 Figure 6. Supernatants from DCC-expressing cells fail to stimulate 
PC12 neurite outgrowth. Conditioned media (supematant) was ob- 
tained from the indicated cell lines after 48 h of culture, in the pres- 
ence (50 ng/ml) or absence of NGF. The conditioned media was 
then used for culture of PC12 cells on monolayers of control 3A3 
cells or DCC-expressing 1AI cells. The mean percentage (+SEM) 
of Thyl  + PC12 cells with at least one neurite  >20 #m in length 
was determined  from three independent experiments and is indi- 
cated. The identity of all experiments was blinded with respect to 
the transfected NII-I3T3 monolayer and treatment,  before assess- 
ment of PC12 neuronal differentiation. 
the conditioned media was collected, filtered through a 0.2- 
#m  filter,  and  then  used  for co-culture  experiments  with 
monolayers of either 1A1 or 3A3 cells. As shown in Fig. 6, 
conditioned media collected from the 1A1 cells appeared to 
have a minimal effect on the induction of neurite outgrowth 
when PC12 cells were co-cultured on 3A3 monolayers. To 
demonstrate that soluble neurite-inducing factors like NGF 
would still retain potency after the prolonged incubation in 
SATO media, NGF was added at 50 ng/mi to the  1A1  and 
3A3  monolayer cultures before the 48-h incubation period 
used for conditioned media collection. Even after 48 h, con- 
ditioned media obtained from cultures  supplemented with 
NGF retained most of the potency expected of NGF for in- 
duction of neurite outgrowth (Fig. 6). Thus, the data suggest 
that supernatants  from DCC-expressing NIH3T3 cells are 
not sufficient for induction  of neurite  outgrowth,  and that 
DCC-mediated PC12 neurite outgrowth requires interaction 
with cells expressing DCC. 
The DCC-mediated Response Is Not Dependent on 
mRNA Synthesis 
Morphological  differentiation  of  PC12  cells  in  response 
to  NGF  treatment  requires  de  novo  synthesis  of mRNA 
(Greene, 1984). To determine whether DCC-mediated PC12 
neurite outgrowth was a transcription-dependent process, we 
compared the effect of cordycepin, an inhibitor of polyade- 
nylation, on neurite outgrowth mediated by DCC-expressing 
1A1  and  control  3A3  monolayers.  As  was previously ob- 
served (Doherty et al.,  1991),  cordycepin substantially in- 
hibited the NGF-mediated response when PC12 cells were 
plated on control cells (Fig. 7). Specifically, 30.2%  +  0.6% 
of the  Thyl  + PC12  cells  were  stimulated  to  differentiate 
when 50 ng/rnl NGF was added to co-cultures with control 
Figure 7. Effects of cordycepin, pertussis toxin, and calcium chan- 
nel blocker  treatment  on NGF- and  DCC-mediated  neurite  out- 
growth.  Control 3A3 or DCC-expressing  1A1 cells were used as 
monolayers for 48 h co-culture of PC12 cells, in the presence (50 
ng/ml) or absence of NGF. Treatment with the transcription inhibi- 
tor cordycepin (1 ~M), permssin toxin (1/~g/ml), and the combina- 
tion of calcium channel blockers (diltiazem at 10 t~M and ~0-cono- 
toxin at 0.25 #M) was begun at the time of addition of PC12 cells 
to the monolayers. The mean percentage (+SEM) of Thyl  + PC12 
cells with at least one neurite >20 #m in length was determined 
from three to seven different experiments with each cell line and 
each treatment (>100 cells analyzed in each experiment). All mea- 
surements were blinded  with  respect to the cell lines and treat- 
merits, before assessment of PC12 neuronal differentiation. 
3A3 cells, while only about 24.2%  5:  1.4%  of Thyl  ÷ PC12 
cells had undergone morphological differentiation when cor- 
dycepin was added. Of note, the background level of neurite 
outgrowth seen on control 3A3 cells in the absence of NGF 
addition was not changed appreciably by cordycepin treat- 
ment (19.5%  +  0.6%  vs.  18.1%  +  0.5%).  Moreover,  as 
shown in Fig.  7,  the DCC-mediated response was not in- 
hibited by cordycepin treatment (38.4%  +  0.7%  vs. 37%  + 
0.7%);  however, the additive effect of NGF on neurite out- 
growth induced by the DCC-expressing  1A1  cells was lost 
upon treatment with cordycepin (42.4%  +  1.3%  vs. 37.3% 
+  1.0%).  The effect of cordycepin on NGF-mediated out- 
growth on control 3A3 monolayers was statistically signifi- 
cant  (P  <  0.02),  but  no  statistically  significant  effect on 
DCC-mediated outgrowth was noted.  These results suggest 
that DCC-stimulated neurite outgrowth, unlike NGF-medi- 
ated outgrowth, does not require de novo transcription. 
Inhibition of  DCC-mediated Neurite Outgrowth by 
Pertussis Toxin and Calcium Channel Antagonists 
Previous studies of N-CAM- and N-cadherin-mediated PC12 
neurite outgrowth have shown that CAM-dependent neurite 
outgrowth, but not NGF-mediated outgrowth, could be in- 
hibited by pertussis toxin and calcium channel antagonists. 
Thus,  CAM-mediated  neurite  outgrowth  may be  effected 
through the activation of L- and N-type calcium channels, as 
well as through a  pertussis toxin-sensitive G  protein (Do- 
herty et al., 1991; Walsh and Doherty, 1992). To identify in- 
tracellular  signaling  pathways  involved in  DCC-mediated 
neurite outgrowth, studies were undertaken to determine if 
treatment with pertussis toxin or calcium channel blockers 
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been shown to ribosylate and inhibit the function of a variety 
of trimeric G proteins of the Go/G~ family. We observed that 
permssis toxin treatment had little effect on the background 
level of neurite outgrowth on 3A3 control monolayers, and 
also failed to inhibit significantly NGF-stimulated neurite 
outgrowth on 3A3 monolayers (Fig. 7). In contrast, pertussis 
toxin strongly inhibited the DCC-mediated response (38.4% 
+  0.7% vs. 22.4%  +  1.6%; P <  0.001). In addition, in the 
presence of pertussis toxin, NGF addition to DCC-express- 
ing 1A1 monolayers failed to fully restore the response to 
control levels (Fig. 7). Thus, the ability of DCC to stimulate 
PC12 neurite outgrowth appears to be dependent upon a per- 
tussis-toxin-sensitive signaling pathway(s). 
To determine whether DCC-mediated neurite outgrowth 
was a  calcium channel-dependent process, we studied the 
effect of the combination of the L-type channel blocker dil- 
tiazem and the N-type channel blocker oJ-conotoxin.  The 
agents were studied only in combination, as previous studies 
had suggested that the effect of the two classes of calcium 
channel antagonist were additive, and that CAM-mediated 
neurite outgrowth was strongly inhibited by the combination 
(Doherty et al., 1991). The combination of calcium channel 
antagonists had little effect on the background level of PC12 
neurite outgrowth induced by control 3A3 cells,  nor was 
there any inhibition of NGF-mediated outgrowth on 3A3 
monolayers (Fig. 7).  The DCC-mediated response was in- 
hibited by the Ca  2+ antagonist combination (38.4 % +  0.7 % 
vs. 29.3%  +  2.2%; P < 0.005), but less markedly than was 
seen with pertussis toxin treatment. These results suggest 
that Ca  2+ channel blockers, while having no effect on NGF- 
mediated neurite outgrowth, inhibit DCC-mediated neurite 
outgrowth in PC12  ceils. 
Discussion 
While previous studies have suggested that the loss of DCC 
gene function may be critical to the later stages of colorectal 
cancer  development,  and perhaps  to  the  development of 
other cancers, little is known about the means by which DCC 
may function to mediate tumor suppression. Similarly, the 
function of the DCC gene in development and cell differenti- 
ation is unknown. In the studies described here, we have used 
a transfection-based approach to examine the role of DCC 
in mediating neuronal cell differentiation  in an in vitro model 
system. Our studies suggest that DCC functions to stimulate 
PC12 neurite outgrowth in a fashion similar to well-charac- 
terized CAMs, such as N-CAM and N-cadherin. The stimu- 
lation of PC12 morphological differentiation by DCC ap- 
pears to require cell-cell interaction. In addition, our results 
suggest that the cytoplasmic domain of DCC is critical for 
inducing differentiation. Furthermore,  like N-CAM-  and 
N-cadherin-mediated PC12 neuritogenesis, the induction of 
neurite outgrowth by DCC appears to be transcription-inde- 
pendent, and utilizes pertussis toxin-sensitive G protein(s) 
and calcium channel-dependent signaling pathways. Thus, in 
addition to the predicted structural similarity of the extracel- 
lular domain sequences of DCC to those of a  number of 
N-CAMs, DCC may share some similarities in its ability to 
alter cell phenotype through cell-ceil interactions. 
A sizeable number of different CAMs can induce contact- 
dependent neuritogenesis in PC12 cells and other neuronal 
cell types. In addition to N-CAM, N-cadherin, and DCC, 
neurite outgrowth has been shown to be supported by non- 
neuronal cells expressing L1, F3/FI 1/contactin, and the my- 
elin associated glycoprotein MAG or Po (W'flliams et al., 
1992;  Gennarini et al.,  1991; Johnson et al.,  1989;  Yazaki 
et al., 1991). Neurite outgrowth can also be triggered by the 
binding of anti-Thy-1 antibodies to PC12 cells. Similar intra- 
cellular signaling pathways may be activated by a number of 
these CAM interactions, because like N-CAM-, LI-, N-cad- 
herin-, and DCC-mediated neurite outgrowth, the induction 
of neurite outgrowth by anti-Thyl  + antibodies could be in- 
hibited by the addition of N- and L-type calcium channel 
blockers or by the addition of pertussis toxin (Doherty et al., 
1993).  Nevertheless, not all neurite-inducing agents use the 
signaling pathways employed by N-CAMs and N-cadherin, 
as neither integrin-mediated nor NGF-mediated PC12 neu- 
rite outgrowth is inhibitable by pertussis toxin or calcium 
channel blockers (Bixby and Jhabvala, 1990; Walsh and Do- 
herty, 1992). 
The role of kinases in N-CAM- and N-cadherin-mediated 
neurite outgrowth has also been studied using a variety of ki- 
nase inhibitors (Doherty et al., 199!). Staurosporine and H7, 
both of which are potent inhibitors of protein kinase C and 
several other protein kinases (Hidaka et al., 1984),  showed 
no  inhibitory effect toward  N-CAM  and  N-cadherin  re- 
sponses (Doherty et al.,  1991). In contrast, K-252b,  which 
is  an  inhibitor  of cAMP-  and  cGMP-dependent kinases 
(Koizumi et al., 1988),  strongly inhibited neurite outgrowth 
by N-CAM and N-cadherin (Doherty et al., 1991). In addi- 
tion, these authors noted that K-252b also lowered the back- 
ground  level  of neurite  outgrowth  promoted  by  control 
fibroblast monolayers. We found that K252b at 200 ng/ml 
demonstrated no specificity in its inhibition of neurite out- 
growth mediated by DCC, NGF, or control fibroblasts.  Simi- 
larly, K-252a, which is a more potent inhibitor of  CAMP- and 
cGMP-dependent kinases than K-252b,  was not useful for 
demonstrating a role for specific protein kinases in the DCC- 
mediated response (PierceaU,  W. E., and E.R. Fearon, un- 
published observations). Thus, at the present, little is known 
about the role of various protein kinases in DCC-induced 
neurite outgrowth. 
Given that control NIH3T3 fibroblast monolayers exhibit 
a relatively consistent background effect on inducing PC12 
neurite outgrowth, it has been proposed that the exogenous 
expression of CAMs in the ceils stimulates increased out- 
growth  from  predetermined  neurites  on  the  PC12  cells 
(Walsh  and Doherty,  1992).  The NIH3T3  cell monolayer 
might  then  serve  as  a  permissive  substrate  for  CAM- 
mediated neurite outgrowth. However,  transfected NIH3T3 
cell monolayers expressing CAMs do not appear to be a 
unique non-neuronal cell type for stimulating neurite out- 
growth (Gennarini et al., 1991). In this regard, we have also 
examined the ability of chinese hamster ovary (CHO) cells 
expressing DCC to induce neurite outgrowth in PC12 cells. 
These  cells  were  capable  of inducing neurite  outgrowth 
above the background level seen with control CHO cell lines; 
however, the absolute magnitude of  both the DCC- and NGF- 
mediated responses was less than that observed with N/H3T3 
cell monolayers (Pierceall, W. E., and E. R. Fearon, unpub- 
lished observations). In addition, in the studies reported here 
we observed no clear-cut relationship between the level of 
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ability of those lines to stimulate neurite outgrowth.  This 
may reflect the fact that lines expressing the full-length DCC 
construct expressed more than the threshold level of DCC 
needed to stimulate PC12 neurite outgrowth. 
The  failure  of supernatants  from DCC-transfected  cell 
lines to induce neurite outgrowth in PC12 cells cultured on 
control  fibroblast monolayers  suggests  that  DCC-induced 
neurite  outgrowth is mediated predominantly  by cell-cell 
contact. To date, no ligand has been identified for DCC. Pre- 
liminary studies suggest that DCC expression does not in- 
crease cell-cell aggregation  when expressed in NIH3T3 cells 
(Fearon,  E.  R.,  unpublished  observations).  However,  as 
reviewed above, anti-sense experiments have suggested that 
DCC  expression  in  PC12  cells  is  necessary  for  NGF- 
mediated neurite outgrowth (Lawlor and Narayanan,  1992). 
Thus, a role for homotypic interactions between DCC mole- 
cules in PC12 neurite outgrowth perhaps should not be ex- 
cluded at this time. Based on the studies described here, we 
infer that PC12 cells synthesize a ligand(s) for DCC. In addi- 
tion,  our  studies  suggest  that  the  cytoplasmic  domain  of 
DCC is necessary for stimulation of PC12 neurite outgrowth. 
Presumably,  this reflects the fact that the DCC cytoplasmic 
domain is necessary for the appropriate  functional interac- 
tion  between  DCC  on  the  NIH3T3  cell  surface  and  its 
ligand(s) on the PC12 cells, perhaps mediated by proper at- 
tachment of DCC to cytoskeletal elements in the NIH3T3 
cells. 
Further  studies will be necessary to define the DCC se- 
quences that are responsible for inducing neuronal differenti- 
ation in PC12 cells. Presently,  little is known about which 
domains in other N-CAM family members are necessary for 
stimulation of neuritogenesis. However, recent data indicate 
that the fourth immunoglobulin domain of the N-CAM mole- 
cule  is  involved  in  neurite  outgrowth  (Horstkorte  et  al., 
1993).  Specifically,  neurite  outgrowth was blocked  when 
oligomaunosidic glyeans specific for binding to the fourth Ig 
domain of N-CAM were added to the cultures;  no effect was 
observed when unrelated  oligosaccharides or oligosaccha- 
ride  derivates  were added.  The  blockage  of neurite  out- 
growth may be due to a destabilization of a N-CAM/L1 com- 
plex that interacts  with L1  on opposing cells (Horstkorte, 
1993). Of note, the sequences in the fourth immunoglobulin 
domain of N-CAM implicated in this process match the con- 
sensus for the eight carbohydrate recognition domains of the 
human  mannose  receptor  (consensus-Cxxxxxx[V/I/L]x[S/ 
T][V/I]xxxx[E/S]  [Taylor et al.,  1990]).  The fourth immu- 
noglobulin domain of DCC  has a  sequence which shares 
similarity  with  this  consensus  (_CTVSGKPVPTVNWM- 
KN). It will be of interest to determine if DCC uses this se- 
quence to participate  in cis-associations with other surface 
molecules like 1.1 or N-CAM to mediate neurite outgrowth. 
In summary, our studies have provided evidence that DCC 
functions in a fashion analogous to other N-CAMs by induc- 
ing  PCl2  neurite outgrowth through  specific intracellular 
signaling pathways. Although this suggests a possible physio- 
logical role for Dec  in effecting changes in cell phenotype 
through cell-cell interactions, much remains to be learned 
about the function of Dec  in vivo.  Further  studies of the 
mechanisms  by which Dec  stimulates  PCl2  neurite out- 
growth may provide insights into its function in other tissues, 
including the means by which DCC may mediate differentia- 
tion and tumor suppression in epithelial  cells. 
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